30 Apr, EOD - Indian

SENSEX 80242.24 (-0.06)

Nifty 50 24334.2 (-0.01)

Nifty Bank 55087.15 (-0.55)

Nifty IT 35794.95 (-0.35)

Nifty Midcap 100 54124.9 (-0.85)

Nifty Next 50 64508.85 (-0.59)

Nifty Pharma 21772.45 (0.44)

Nifty Smallcap 100 16448.85 (-1.73)

30 Apr, EOD - Global

NIKKEI 225 36045.38 (0.57)

HANG SENG 22119.41 (0.51)

S&P 5467.23 (-2.05)

LOGIN HERE

companylogoDenis Chem Lab Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 537536 | NSE Symbol : | ISIN : INE051G01012 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
01-Feb-2025 14-Feb-2025 Quarterly Results Denis Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended on 31st December 2024. Outcome of Board Meeting - Submission of Unaudited Financial Results for the Quarter ended on 31st December, 2024 (As Per BSE Announcement Dated on 14.02.2025)
29-Oct-2024 14-Nov-2024 Quarterly Results Quarterly Results Denis Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended on 30th September, 2024. (As Per BSE Announcement dated on 29.10.2024) Board of Directors in their meeting held today, have taken on record the Unaudited Financial Results for the quarter ended on 30th September, 2024. (As per BSE Announcement dated on 14/11/2024)
02-Aug-2024 14-Aug-2024 Quarterly Results Denis Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended on 30th June 2024. We are enclosing herewith copy of the said Unaudited Financial Results for the quarter ended on 30th June, 2024 along with Limited Review Report thereon. (As Per BSE Announcement dated on 14.08.2024)
24-Jul-2024 24-Jul-2024 AGM The board has decided Date of Annual General Meeting, Book Closure & E-voting and other matters. The Board has decided and approved the appointment of Independent Directors subject to approval of shareholders.
13-May-2024 28-May-2024 Accounts Denis Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 inter alia to consider and approve and take on record the Audited Standalone Financial Results of the Company for the financial year 2023-24 ended on 31st March 2024; 2. To recommend a final dividend if any on the equity shares of the Company for the financial year 2023-24 ended on 31st March 2024. Please note that the Board of Directors of the Company, in their meeting held today i.e. on 28th May, 2024, interalia, has: 1. Approved the Standalone Audited Financial Statements of the Company for Quarter and Financial Year ended on 31st March, 2024 as recommended by the Audit Committee. 2. Recommended a Final dividend of Rs.2.50 per Equity Share of Rs.10/- each for the financial year 2023-24 ended on 31st March, 2024, subject to approval of shareholders at the ensuing Annual General Meeting. (As Per BSE Announcement Dated on: 28/05/2024)
01-Feb-2024 14-Feb-2024 Quarterly Results Denis Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended on 31st December 2023. Submission of Unaudited Financial Results for the Quarter ended on 31st December, 2023 We are enclosing herewith unaudited financial results along with Limited review report for the quarter ended on 31st December, 2023. (As Per BSE Announcement Dated on 14/02/2024)
26-Oct-2023 07-Nov-2023 Quarterly Results Denis Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 inter alia to consider and approve to consider and approve the Unaudited Financial Results of the Company for the quarter ended on 30th September 2023 We are enclosing herewith copy of the said Unaudited Financial Results for the quarter ended on 30th September, 2023 along with Limited Review Report thereon. Submitting herewith Unaudited Financial Result for quarter ended 30th September, 2023 along with Limited Review Report (As Per BSE Announcement Dated on 07/11/2023)
02-Aug-2023 14-Aug-2023 Quarterly Results Denis Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 inter alia to consider and approve Unaudited Financial Results For The Quarter Ended On 30Th June 2023. The Board of Directors in their meeting held today, have taken on record the Unaudited Financial Results for the quarter ended on 30th June, 2023. We are enclosing herewith copy of the said Unaudited Financial Results for the quarter ended 30th June, 2023 along with Limited Review Report thereon. The Board of Directors of the Company in their meeting held today, have taken on records the unaudited financial results for the quarter ended on 30th June, 2023. We are enclosing herewith copy of the said unaudited financial results for the quarter ended on 30th June, 2023 along with limited review report thereon. (As Per BSE Announcement Dated on 14.08.2023)
17-Jul-2023 17-Jul-2023 AGM Outcome Of Board Meeting - Intimation Of Date Of Annual General Meeting, Book Closure, Cut off date for dividend & E-Voting & Other Proposed Matters. The Board has re appointed Dr. Himanshu C. Patel as Managing Director subject to approval of Shareholders. The Board has decided Book Closure / Record Date for the purpose of Dividend at the AGM, if declared.
16-May-2023 30-May-2023 Accounts Denis Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve and take on record the Audited Standalone Financial Results of the Company for the financial year 2022-23 ended on 31st March 2023; to recommend a final dividend if any on the equity shares of the Company for the financial year 2022-23 ended on 31st March 2023. The Board of Directors of the Company, in their meeting held today i.e. on 30th May, 2023, interalia, has: Recommended a Final dividend of Rs. 2/- per Equity Share of Rs.10/- each for the financial year 2022-23 ended on 31st March, 2023, subject to approval of shareholders at the ensuing Annual General Meeting. Please note that the Board of Directors of the Company, in their meeting held today i.e. on 30thMay, 2023,interalia, has: 1. Approved the Standalone Audited Financial Statements of the Company for Quarter and Financial Year ended on 31st March, 2023 as recommended by the Audit Committee. 2. Recommended a Final dividend of Rs.2/- per Equity Share of Rs.10/- each for the financial year 2022-23 ended on 31stMarch, 2023, subject to approval of shareholders at the ensuing Annual General Meeting. Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, we enclosethe following: 1. Statement of Audited Financial Results for the financial year ended on 31st March, 2023. 2. Auditors' Report on the Audited Financial Results for the financial year ended on 31st March, 2023. 3. Declaration to the effect that there is Unmodified Opinion with respect to Audited Financial Results for the financial year ended on 31st March, 2023. (As Per BSE Announcement dated on 30.05.2023)
01-Feb-2023 14-Feb-2023 Quarterly Results Quarterly Results Denis Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended on 31st December, 2022 Please note that the Board of Directors in their meeting held today i.e., on 14th February, 2023, have taken on record the Unaudited Financial Results for the quarter ended on 31st December, 2022. We are enclosing herewith copy of the said Unaudited Financial Results for the quarter ended on 31st December, 2022 along with Limited Review Report thereon. (As per BSE Announcement Dated on 14/02/2023)
03-Nov-2022 14-Nov-2022 Quarterly Results Denis Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended on 30th September 2022. Please note that as intimated to the Exchange vide Letter dated 26th September 2022 the Trading Window of the Company shall continue to remain closed for designated persons till 48 hours after the declaration of Financial Results for the quarter ended on 30th September 2022 in terms of Companys Code of Conduct for prevention of Insider Trading and SEBI (Prohibition of Insider Trading) Regulations 2015. Please note that the Board of Directors in their meeting held today, have taken on record the Unaudited Financial Results for the quarter ended on 30th September, 2022. We are enclosing herewith copy of the said Unaudited Financial Results for the quarter ended on 30th September, 2022 along with Limited Review Report thereon. The Meeting of Board of Directors was commenced at 10:00 a.m. and concluded at 12:45 p.m. Please note that the Board of Directors in their meeting held today, have taken on record the Unaudited Financial Results for the quarter ended on 30th September, 2022. We are enclosing herewith copy of the said Unaudited Financial Results for the quarter ended on 30th September, 2022 along with Limited Review Report thereon. The Meeting of Board of Directors was commenced at 10:00 a.m. and concluded at 12:45 p.m. (As Per BSE Announcement Dated on 14.11.2022)
01-Aug-2022 10-Aug-2022 Quarterly Results Denis Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2022 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended on 30th June 2022. We refer to our letter dated 1st August, 2022 informing the date of Meeting of the Board of Directors of the Company, please note that the Board of Directors in their meeting held today, have taken on record the Un-audited Financial Results for the quarter ended on 30th June, 2022. We are enclosing herewith copy of the said Unaudited Financial Results for the quarter ended on 30th June, 2022 along with Limited Review Report thereon. This is as per Regulation - 33 and other applicable provisions of the SEBI (LODR) Regulations, 2015. Thanking you, (As Per BSE Announcement dated on 10.08.2022)
19-Jul-2022 19-Jul-2022 AGM Outcome Of Board Meeting - Intimation Of Date Of Annual General Meeting, Book Closure, Cut off date for dividend & E-Voting & Other Proposed Matters. The Board of Directors in their meeting held today have fixed Book Closure for the 41St AGM of the Company.
06-May-2022 26-May-2022 Accounts Denis Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2022 inter alia to consider and approve With reference to the above and pursuant to Regulation 29 of SEBI (LODR) Regulations 2015 we wish to inform you that the next Meeting of the Board of Directors of the Company is scheduled to be held on Thursday the 26th May 2022 to transact inter alia the following: 1. to consider approve and take on record the Audited Standalone Financial Results of the Company for the financial year 2021-22 ended on 31st March 2022; 2. to recommend a final dividend if any on the equity shares of the Company for the financial year 2021-22 ended on 31st March 2022. Please note that the Board of Directors of the Company, in their meeting held today i.e. on 26thMay, 2022,interalia,has recommended a Final dividend of Rs.1.50(@15%) per Equity Share of Rs.10/- each for the financial year 2021-22 ended on 31stMarch, 2022, subject to approval of shareholders at the ensuing Annual General Meeting. Please note that the Board of Directors of the Company, in their meeting held today i.e. on 26thMay, 2022,interalia,has: 1. Approved the Standalone Audited Financial Statements of the Company for Quarter and Financial Year ended on 31st March, 2022 as recommended by the Audit Committee. 2. Recommended a Final dividend of Rs.1.50(15%) per Equity Share of Rs.10/- each for the financial year 2021-22 ended on 31stMarch, 2022, subject to approval of shareholders at the ensuing Annual General Meeting. Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, we enclose the following: 1. Statement of Audited Financial Results for the financial year ended on 31st March, 2022. 2. Auditors' Report on the Audited Financial Results for the financial year ended on 31st March, 2022. 3. Declaration to the effect that there is Unmodified Opinion with respect to Audited Financial Results for the financial year ended on 31st March, 2022. (As Per BSE Announcement Dated on 26.05.2022)
1 2 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +